SRC and breast carcinoma: For example, magnolol can inhibit the expression of lysyl oxidase from disrupting FAK/Src/paxillin signaling to inhibit the migration and invasion of breast cancer cells, which is considered to be an ideal strategy for breast cancer treatment [170].